blindness and tirzepatide Semaglutide, Linked to Small Increase in Eye Disorder Risk tirzepatide eye issues Study link:

This risk is particularly important if you are also taking insulin or sulfonylureas alongside Ozempic, as these combinations increase hypoglycaemia risk and may require dose adjustments of those medications

International orders: Email [email protected] for a custom quote Description DESCRIPTION SLU-PP-332 100mcg x 100 Capsules is a synthetic small-molecule investigational compound characterized as a pan-agonist of the estrogen-related receptor (ERR) family, with reported binding affinity toward the ERR isoform

While evidence suggests GLP-1 receptor agonists have protective effects against arterial disease, the evidence specifically examining venous thrombosis risk is more limited, though no safety signals have emerged

Many of these strategies work by mimicking effects similar to those of Ozempic, such as slowing digestion, curbing appetite, and improving insulin sensitivity